A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies
Open Access
- 20 September 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (18)
Abstract
Zebrafish are a powerful tool for studying muscle function owing to their high numbers of offspring, low maintenance costs, evolutionarily conserved muscle functions, and the ability to rapidly take up small molecular compounds during early larval stages. Fukutin-related protein (FKRP) is a putative protein glycosyltransferase that functions in the Golgi apparatus to modify sugar chain molecules of newly translated proteins. Patients with mutations in the FKRP gene can have a wide spectrum of clinical symptoms with varying muscle, eye, and brain pathologies depending on the location of the mutation in the FKRP protein. Patients with a common L276I FKRP mutation have mild adult-onset muscle degeneration known as limb-girdle muscular dystrophy 2I (LGMD2I), whereas patients with more C-terminal pathogenic mutations develop the severe Walker-Warburg syndrome (WWS)/muscle-eye-brain (MEB) disease. We generated fkrp -mutant zebrafish that phenocopy WWS/MEB pathologies including severe muscle breakdowns, head malformations, and early lethality. We have also generated a milder LGMD2I-model zebrafish via overexpression of a heat shock–inducible human FKRP (L276I) transgene that shows milder muscle pathology. Screening of an FDA-approved drug compound library in the LGMD2I zebrafish revealed a strong propensity towards steroids, antibacterials, and calcium regulators in ameliorating FKRP-dependent pathologies. Together, these studies demonstrate the utility of the zebrafish to both study human-specific FKRP mutations and perform compound library screenings for corrective drug compounds to treat muscular dystrophies.Keywords
Funding Information
- Norges Idrettshøgskole (5R25NS089463)
- Norges Idrettshøgskole (2T32HD071866-06)
- Limb Girdle Muscular Dystrophy 2I (Direct Award)
- Muscular Dystrophy Association (418254)
This publication has 75 references indexed in Scilit:
- Targeted gene disruption in somatic zebrafish cells using engineered TALENsNature Biotechnology, 2011
- Dystroglycanopathies: coming into focusCurrent Opinion in Genetics & Development, 2011
- mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle MassCell Metabolism, 2011
- Drug screening in a zebrafish model of Duchenne muscular dystrophyProceedings of the National Academy of Sciences, 2011
- Embedding, serial sectioning and staining of zebrafish embryos using JB-4 resinNature Protocols, 2010
- Targeted mutagenesis in zebrafish using customized zinc-finger nucleasesNature Protocols, 2009
- Hematopoietic Stem Cell Development Is Dependent on Blood FlowCell, 2009
- The Tol2kit: A multisite gateway‐based construction kit for Tol2 transposon transgenesis constructsDevelopmental Dynamics, 2007
- FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafishDevelopmental Biology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001